AWK vs BBIO
American Water Works (AWK) versus BridgeBio Pharma Inc (BBIO) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. BBIO currently screens at market cap $13.24B.
Not investment advice. Open the AWK and BBIO stock pages for the full models.
Not investment advice.